Browse
Register
Log In
Variables
4291 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
Heart rate variability (CHRIS baseline)
x0ec282
RPA Shannon Entropy
RPA Shannon Entropy: it is the entropy of the probability distribution of the diagonal line lengths
Float
Flavonoid intake (CHRIS baseline)
x0fl004
Total daily flavan-3-ols
Total daily flavan-3-ols
Float
Heart rate variability (CHRIS baseline)
x0ec283a
MSE (t=1)
MSE (t=1): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 1
Float
Heart rate variability (CHRIS baseline)
x0ec283b
MSE (t=2)
MSE (t=2): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 2
Float
Flavonoid intake (CHRIS baseline)
x0fl005
Total daily flavonols
Total daily flavonols
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt011
Glu
Glutamate
Float
Heart rate variability (CHRIS baseline)
x0ec279
RPA divergence
RPA divergence: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. The divergence (DIV) is defined as the inverse of Lmax
Float
Heart rate variability (CHRIS baseline)
x0ec277
RPA recurrence rate
RPA recurrence rate: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. The recurrence rate (REC) is defined as the ratio of ones and zeros in this RP matrix
Float
Blood measurements (CHRIS baseline)
x0lp26a
Magnesium (Mg)
Magnesium (Mg)
Float
Smoking (CHRIS baseline)
x0sm06d
Interruption duration cigarette smoking, v.1
Interruption duration cigarette smoking, v.1
Float
ECG 10s (CHRIS baseline)
x0ec106l
P-Amplitude negative, V6
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V6
Float
Blood measurements (CHRIS baseline)
x0lp26
Magnesium (Mg)
Magnesium (Mg)
Float
ECG 10s (CHRIS baseline)
x0ec106k
P-Amplitude negative, V5
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V5
Float
Heart rate variability (CHRIS baseline)
x0ec283c
MSE (t=3)
MSE (t=3): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 3
Float
Chronic pain (CHRIS baseline)
x0pn22
Other pain since (years)
Since when is this pain present? (years)
Float
Anthropometry (CHRIS baseline)
x0an01
Height
Height
Float
Blood measurements (CHRIS baseline)
x0lp50j
Basophils (absolute basophil count)
Basophils (absolute basophil count)
Float
Heart rate variability (CHRIS baseline)
x0ec276
DFA alpha2
DFA alpha2: Detrended Fluctuation Analysis measures the correlation within the signal. Slope alpha2 characterizes long-term fluctuations or the RR series
Float
Blood measurements (CHRIS baseline)
x0lp06a
Glycated hemoglobin (HbA1c)
Glycated hemoglobin (HbA1c)
Float
Anthropometry (CHRIS baseline)
x0an03a
Body Mass Index
Body Mass Index
Float
ECG 10s (CHRIS baseline)
x0ec131b
J-Value, II
J point voltage value, expressed in milliVolts, measured in lead II
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt019
Met
Methionine
Float
ECG 10s (CHRIS baseline)
x0ec106i
P-Amplitude negative, V3
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V3
Float
Flavonoid intake (CHRIS baseline)
x0fl006
Total daily flavones
Total daily flavones
Float
Heart rate variability (CHRIS baseline)
x0ec278
RPA determinism
RPA determinism: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. The determinism (DET) is defined as the percentage of recurrence points which form diagonal lines
Float
Heart rate variability (CHRIS baseline)
x0ec268
Poincare SD1
Poincare SD1: in Poincare plot, SD1 represents the standard deviation perpendicular to the line-of-identity
Float
ECG 10s (CHRIS baseline)
x0ec106h
P-Amplitude negative, V2
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V2
Float
Heart rate variability (CHRIS baseline)
x0ec269
Poincare SD2
Poincare SD2: in Poincare plot, SD2 represents the standard deviation along the line-of-identity
Float
Heart rate variability (CHRIS baseline)
x0ec267
EDR (ECG Derived Respiration)
EDR (ECG Derived Respiration), expressed in Hz
Float
ECG 10s (CHRIS baseline)
x0ec106g
P-Amplitude negative, V1
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V1
Float
Heart rate variability (CHRIS baseline)
x0ec270
Poincare SD2/SD1
Poincare SD2/SD1: ratio between SD2 and SD1
Float
Chronic pain (CHRIS baseline)
x0pn02
Back pain since (years)
Since when is the back pain present? (years)
Float
Heart rate variability (CHRIS baseline)
x0ec264
LF power (n.u.) (AR)
Power of LF band in normalised units, LF [n.u.] = LF [ms2] / (total power [ms2] - VLF [ms2]) x 100%, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in n.u
Float
ECG 10s (CHRIS baseline)
x0ec106f
P-Amplitude negative, aVF
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVF
Float
Heart rate variability (CHRIS baseline)
x0ec265
HF power (n.u.) (AR)
Power of HF band in normalised units, HF [n.u.] = LF [ms2] / (total power [ms2] - VLF [ms2]) x 100%, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in n.u.
Float
Heart rate variability (CHRIS baseline)
x0ec266
LF/HF power (AR)
Ratio between LF and HF band powers, with PSD estimated using parametric autoregressive (AR) modeling method
Float
ECG 10s (CHRIS baseline)
x0ec106e
P-Amplitude negative, aVL
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVL
Float
Heart rate variability (CHRIS baseline)
x0ec272
Approximate Entropy
Approximate Entropy: measures the complexity or irregularity of the signal. Large values of ApEn indicate high irregularity and smaller values of ApEn more regular signal
Float
Heart rate variability (CHRIS baseline)
x0ec283t
MSE (t=20)
MSE (t=20): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 20
Float
Heart rate variability (CHRIS baseline)
x0ec258
logLF power (AR)
Natural logarithm transformed values of LF band, with PSD estimated using parametric autoregressive (AR) modeling method
Float
ECG 10s (CHRIS baseline)
x0ec106d
P-Amplitude negative, aVR
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVR
Float
Heart rate variability (CHRIS baseline)
x0ec259
logHF power (AR)
Natural logarithm transformed values of HF band, with PSD estimated using parametric autoregressive (AR) modeling method
Float
Blood measurements (CHRIS baseline)
x0lp50i
Eosinophils (absolute eosinophil count)
Eosinophils (absolute eosinophil count)
Float
ECG 10s (CHRIS baseline)
x0ec106c
P-Amplitude negative, III
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead III
Float
Heart rate variability (CHRIS baseline)
x0ec237
LF power (Welch)
Absolute power of LF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in ms^2
Float
Heart rate variability (CHRIS baseline)
x0ec260
logtot power (AR)
Natural logarithm transformed values of total spectrum power, with PSD estimated using parametric autoregressive (AR) modeling method
Float
Heart rate variability (CHRIS baseline)
x0ec254
LF power (AR)
Absolute power of LF band, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in ms^2
Float
ECG 10s (CHRIS baseline)
x0ec106b
P-Amplitude negative, II
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead II
Float
Heart rate variability (CHRIS baseline)
x0ec255
HF power (AR)
Absolute power of HF band, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in ms^2
Float
ECG 10s (CHRIS baseline)
x0ec106a
P-Amplitude negative, I
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead I
Float
Heart rate variability (CHRIS baseline)
x0ec256
total power (AR)
Absolute power of the total spectrum, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in ms^2
Float
Heart rate variability (CHRIS baseline)
x0ec262
LF power (%) (AR)
Relative power of LF band, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in ms^2
Float
Heart rate variability (CHRIS baseline)
x0ec273
Sample Entropy
Sample Entropy: similar to ApEn, but it presents some differences in the calculation
Float
Heart rate variability (CHRIS baseline)
x0ec249
LF-HF power (Welch)
Ratio between LF and HF band powers, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method
Float
ECG 10s (CHRIS baseline)
x0ec105l
P-Amplitude positive, V6
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V6
Float
Heart rate variability (CHRIS baseline)
x0ec250
VLF peak (AR)
Very Low Frequency (VLF) band peak frequency, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in Hz
Float
Blood measurements (CHRIS baseline)
x0lp25a
Phosphorus (P)
Phosphorus (P)
Float
ECG 10s (CHRIS baseline)
x0ec105k
P-Amplitude positive, V5
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V5
Float
Heart rate variability (CHRIS baseline)
x0ec248
HF power (n.u.) (Welch)
Power of HF band in normalised units, HF [n.u.] = LF [ms2] / (total power [ms2] - VLF [ms2]) x 100%, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in n.u.
Float
Heart rate variability (CHRIS baseline)
x0ec251
LF peak (AR)
Low Frequency (LF) band peak frequency, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in Hz
Float
Heart rate variability (CHRIS baseline)
x0ec244
VLF power (%) (Welch)
Relative power of VLF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in ms^2
Float
ECG 10s (CHRIS baseline)
x0ec105j
P-Amplitude positive, V4
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V4
Float
Heart rate variability (CHRIS baseline)
x0ec245
LF power (%) (Welch)
Relative power of LF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in ms^2
Float
Blood measurements (CHRIS baseline)
x0lp50h
Monocytes (absolute monocyte count)
Monocytes (absolute monocyte count)
Float
ECG 10s (CHRIS baseline)
x0ec105i
P-Amplitude positive, V3
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V3
Float
Heart rate variability (CHRIS baseline)
x0ec246
HF power (%) (Welch)
Relative power of HF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in ms^2
Float
Heart rate variability (CHRIS baseline)
x0ec252
HF peak (AR)
High Frequency (HF) band peak frequency, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in Hz
Float
Heart rate variability (CHRIS baseline)
x0ec275
DFA alpha1
DFA alpha1: Detrended Fluctuation Analysis measures the correlation within the signal. Slope alpha1 characterizes short-term fluctuations or the RR series
Float
Heart rate variability (CHRIS baseline)
x0ec239
total power (Welch)
Absolute power of the total spectrum, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in ms^2
Float
ECG 10s (CHRIS baseline)
x0ec105g
P-Amplitude positive, V1
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V1
Float
Heart rate variability (CHRIS baseline)
x0ec241
logLF power (Welch)
Natural logarithm transformed values of LF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method
Float
Blood measurements (CHRIS baseline)
x0lp25
Phosphorus (P)
Phosphorus (P)
Float
ECG 10s (CHRIS baseline)
x0ec105f
P-Amplitude positive, aVF
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVF
Float
Heart rate variability (CHRIS baseline)
x0ec238
HF power (Welch)
Absolute power of HF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in ms^2
Float
Heart rate variability (CHRIS baseline)
x0ec242
logHF power (Welch)
Natural logarithm transformed values of HF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method
Float
Flavonoid intake (CHRIS baseline)
x0fl007
Total daily Polymers
Total daily Polymers
Float
ECG 10s (CHRIS baseline)
x0ec105e
P-Amplitude positive, aVL
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVL
Float
Flavonoid intake (CHRIS baseline)
x0fl040
Total daily Pro monomers
Total daily Pro monomers
Float
Blood measurements (CHRIS baseline)
x0lp50g
Lymphocytes (absolute lymphocyte count)
Lymphocytes (absolute lymphocyte count)
Float
ECG 10s (CHRIS baseline)
x0ec105d
P-Amplitude positive, aVR
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVR
Float
Blood measurements (CHRIS baseline)
x0lp02d
Activated partial thromboplastin time (aPTT)
Activated partial thromboplastin time (aPTT)
Float
Heart rate variability (CHRIS baseline)
x0ec243
logtot power (Welch)
Natural logarithm transformed values of total spectrum power, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method
Float
Heart rate variability (CHRIS baseline)
x0ec253
VLF power (AR)
Absolute power of VLF band, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in ms^2
Float
Heart rate variability (CHRIS baseline)
x0ec283d
MSE (t=4)
MSE (t=4): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 4
Float
Chronic pain (CHRIS baseline)
x0pn12
Joint pain since (years)
Since when is the joint pain present? (years)
Float
Heart rate variability (CHRIS baseline)
x0ec227
HRV triangular index
HRV triangular index: integral of the histogram (i.e. total number of RR intervals) divided by the height of the histogram computed with a bin width of 1/128 seconds
Float
ECG 10s (CHRIS baseline)
x0ec105c
P-Amplitude positive, III
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead III
Float
Heart rate variability (CHRIS baseline)
x0ec225
max HR
Maximum HR computed using N=5 beat moving average
Float
ECG 10s (CHRIS baseline)
x0ec105b
P-Amplitude positive, II
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead II
Float
Heart rate variability (CHRIS baseline)
x0ec229
AC
AC: Acceleration Capacity captures the shortening of RR interval within 2-4 successive beats. It is computed as a four point difference from the acceleration PRSA signal (phase-rectified signal averaging), expressed in milliseconds
Float
Heart rate variability (CHRIS baseline)
x0ec222
mean HR
Mean heart rate, expressed in beats per minute
Float
Heart rate variability (CHRIS baseline)
x0ec223
std HR
Standard deviation of heart rate
Float
Blood measurements (CHRIS baseline)
x0lp50f
Neutrophils (absolute neutrophil count)
Neutrophils (absolute neutrophil count)
Float
Heart rate variability (CHRIS baseline)
x0ec224
min HR
Minimum HR computed using N=5 beat moving average
Float
Heart rate variability (CHRIS baseline)
x0ec231
ACmod
ACmod: modified Acceleration Capacity, computed according to the formula given in Nasario-Junior et al. 2014, expressed in milliseconds
Float
Heart rate variability (CHRIS baseline)
x0ec219
pNN50
pNN50: NN50 divided by the total number of RR intervals
Float
Heart rate variability (CHRIS baseline)
x0ec217
RMSSD
RMSSD: Square root of the mean squared differences between successive RR intervals, expressed in milliseconds
Float
Heart rate variability (CHRIS baseline)
x0ec220
SDANN
SDANN: Standard deviation of the averages of RR intervals in 5-min segments, expressed in milliseconds
Float
Heart rate variability (CHRIS baseline)
x0ec232
DCmod
DCmod: modified Deceleration Capacity, computed according to the formula given in Nasario-Junior et al. 2014, expressed in milliseconds
Float
Heart rate variability (CHRIS baseline)
x0ec214c
SNS param: nSD2
Third parameter used for SNS index calculation: SD2 normalized by scaling with the standard deviations of normal population
Float
Previous
1
9
10
11
12
13
43
Next